Report
Report of RSNN session @ FIGON DMD/EUFEPS 2022 meeting now available
12 July 2022
On 2 June 2022 the RSNN hosted a parallel session during the FIGON & EUFEPS European medicines days (www.figondmd.nl) in the Stadsgehoorzaal in Leiden. The session was chaired by Sini Eskola (EFPIA) and speakers from different backgrounds were present.
In three presentations, followed by a plenary discussion, the views from academia, industry and regulator were discussed with regard to academic drug development. Furthermore, speakers debated about the way academic drug development can potentially have added value and the hurdles to overcome for academic drug development in the route to market authorisation and beyond.
The full report including the key takeaways from the meeting is now available for download here: link (PDF file)